Episode: 155 - Bill Taranto on Merck’s Global Health Innovation (GHI) Fund and Using Multiple Assets with Groundbreaking Technology to Solve Major Digital Health Problems

<p> When Bill Taranto pitched the Global Health Innovation (GHI) Fund, he envisioned an independent venture that mimicked a private firm but maintained the backing and power of a big health company. The Fund&apos;s partnership with Merck allows them to make groundbreaking investments in the digital health space. Following what is often known as &quot;ecosystem investing,&quot; the GHI Fund matches two or more companies, each solving a portion of a healthcare problem, to solve the issue effectively and thoroughly. In addition, GHI maintains a strong focus on the future of healthcare, including patient identification and aggregation as well as data security, integration, analytics, and informatics. Boasting a success rate of over 95%, Bill talks about GHI&apos;s mission to scale companies using an integrated approach, data science, and revolutionary technology. <br/><br/><b>Links from this episode:</b> <br/><a href='https://www.merckghifund.com/'>GHI Fund</a> </p><p><br/><br/><br/></p>